Chinese Journal of Chromatography ›› 2022, Vol. 40 ›› Issue (6): 531-540.DOI: 10.3724/SP.J.1123.2021.12009
• Articles • Previous Articles Next Articles
XU Hongbin, ZHANG Shenping(), DU Ruyun, ZHOU Jing, WENG Shiyu
Received:
2021-12-09
Online:
2022-06-08
Published:
2022-05-26
Contact:
ZHANG Shenping
Supported by:
CLC Number:
XU Hongbin, ZHANG Shenping, DU Ruyun, ZHOU Jing, WENG Shiyu. Ultra-high performance liquid chromatography-orbitrap high-resolution mass spectrometry for rapid screening and identification of 32 illegally added drugs in slimming and anti-impotence health foods[J]. Chinese Journal of Chromatography, 2022, 40(6): 531-540.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chrom-china.com/EN/10.3724/SP.J.1123.2021.12009
No. | Compound | Formula | Measured mass (m/z) | Fragments (m/z) | tR/min | Adduct | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 | avanafil (阿伐那非) | C23H26ClN7O3 | 484.18585 | 375.12159, 233.10332 | 6.00 | [M+H]+ | |||||
2 | acetilacid (那非乙酰酸) | C18H20N4O4 | 357.15515 | 329.12390, 300.08511 | 6.85 | [M+H]+ | |||||
3 | dapoxetine (达泊西汀) | C21H23NO | 306.18439 | 261.12695, 183.08032 | 6.67 | [M+H]+ | |||||
4 | xanthoanthrafil (苯酰胺那非) | C19H23N3O6 | 390.16553 | 151.07516, 135.04373 | 6.95 | [M+H]+ | |||||
5 | piperiacetidenafil (苯噻啶红地那非) | C24H31N5O3 | 438.24939 | 297.12422, 341.16089 | 5.93 | [M+H]+ | |||||
6 | benzocaine (苯佐卡因) | C9H11NO2 | 166.08601 | 138.05492, 120.04429 | 6.31 | [M+H]+ | |||||
7 | bendroflumethiazide (苄氟噻嗪) | C15H14F3N3O4S2 | 420.03149 | 289.04599, 327.96851 | 7.13 | [M-H]- | |||||
8 | yohimbine (育亨宾) | C21H26N2O3 | 355.20090 | 212.12802, 144.08075 | 5.43 | [M+H]+ | |||||
9 | hydroxyacetildenafil (羟基红地那非) | C25H34N6O4 | 483.27103 | 297.13419, 127.08654 | 5.73 | [M+H]+ | |||||
10 | hydroxythiohomo sildenafil (羟基硫代豪莫西地那非) | C23H32N6O4S2 | 521.19958 | 299.09589, 327.12759 | 6.74 | [M+H]+ | |||||
11 | hydroxyvardenafil (羟基伐地那非) | C23H32N6O5S | 505.22235 | 344.14746, 169.09691 | 5.73 | [M+H]+ | |||||
12 | thiohomo sildenafil (硫代豪莫西地那非) | C23H32N6O3S2 | 505.20401 | 299.09607, 113.10741 | 6.92 | [M+H]+ | |||||
13 | thiosildenafil (硫代西地那非) | C22H30N6O3S2 | 491.18918 | 341.14389, 407.12027 | 6.82 | [M+H]+ | |||||
14 | N-desmethylsibutramine hydrochloride | C16H24ClN·HCl | 266.16666 | 125.01524, 139.03091 | 6.72 | [M+H]+ | |||||
(盐酸N-单去甲基西布曲明) | |||||||||||
15 | N,N-didesmethylsibutramine hydrochloride | C15H22ClN·HCl | 252.15092 | 125.01521, 139.03085 | 6.69 | [M+H]+ | |||||
(盐酸N,N-双去甲基西布曲明) | |||||||||||
16 | chlorthalidone (氯噻酮) | C14H11CLN2O4S | 337.00583 | 146.02345, 189.97272 | 5.70 | [M-H]- | |||||
17 | lorcaserin (氯卡色林) | C11H14ClN | 196.08885 | 179.06218, 167.06212 | 5.52 | [M+H]+ | |||||
18 | hydrochlorothiazide (氢氯噻嗪) | C7H8ClN3O4S2 | 295.95804 | 268.94708, 204.98419 | 3.06 | [M-H]- | |||||
19 | torasemide (托拉塞米) | C16H20N4O3S | 347.11835 | 262.06564, 195.07954 | 6.04 | [M-H]- | |||||
20 | gendenafil (庆地那非) | C19H22N4O3 | 355.17612 | 327.14514, 285.13467 | 7.44 | [M+H]+ | |||||
21 | emodin (大黄素) | C15H10O5 | 269.04623 | 225.05583, 241.05090 | 8.11 | [M-H]- | |||||
22 | indapamide (吲达帕胺) | C16H16O3N3ClS | 366.06686 | 132.08073, 117.05728 | 6.75 | [M+H]+ | |||||
23 | desmethyl sildenafil (去甲基西地那非) | C21H28N6O4S | 461.19626 | 283.11868, 255.12376 | 5.97 | [M+H]+ | |||||
24 | desmethyl thiosildenafil (去甲基硫代西地那非) | C21H28N6O3S2 | 477.17288 | 299.09586, 315.09033 | 6.79 | [M+H]+ | |||||
25 | nortadalafil (去甲他达拉非) | C21H17N3O4 | 376.12857 | 262.08588, 254.09195 | 6.69 | [M+H]+ | |||||
No. | Compound | Formula | Measured mass (m/z) | Fragments (m/z) | tR/min | Adduct | |||||
26 | N-desethyl acetildenafil (去乙基红地那非) | C23H30N6O3 | 439.24466 | 297.13419, 313.12927 | 5.78 | [M+H]+ | |||||
27 | N-desethyl vardenafil (去乙基伐地那非) | C21H28N6O4S | 461.19577 | 344.14749, 299.11346 | 5.97 | [M+H]+ | |||||
28 | rimonabant (利莫那班) | C22H21Cl3N4O | 463.08517 | 380.99548, 299.01343 | 9.08 | [M+H]+ | |||||
29 | lidocaine (利多卡因) | C14H22N2O | 235.18016 | 86.09662, 58.06575 | 4.33 | [M+H]+ | |||||
30 | chlorpretadalafil (他达拉非甲基氯化物) | C22H19ClN2O5 | 337.00583 | 146.02345, 189.97272 | 7.91 | [M+H]+ | |||||
31 | dimethylsildenafil (二甲基西地那非) | C23H32N6O4S | 489.22803 | 283.11920, 344.14856 | 6.14 | [M+H]+ | |||||
32 | udenafil (乌地那非) | C25H36N6O4S | 517.25854 | 283.11874, 299.11380 | 6.22 | [M+H]+ |
Table 1 UHPLC-HRMS parameters for the 32 compounds
No. | Compound | Formula | Measured mass (m/z) | Fragments (m/z) | tR/min | Adduct | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 | avanafil (阿伐那非) | C23H26ClN7O3 | 484.18585 | 375.12159, 233.10332 | 6.00 | [M+H]+ | |||||
2 | acetilacid (那非乙酰酸) | C18H20N4O4 | 357.15515 | 329.12390, 300.08511 | 6.85 | [M+H]+ | |||||
3 | dapoxetine (达泊西汀) | C21H23NO | 306.18439 | 261.12695, 183.08032 | 6.67 | [M+H]+ | |||||
4 | xanthoanthrafil (苯酰胺那非) | C19H23N3O6 | 390.16553 | 151.07516, 135.04373 | 6.95 | [M+H]+ | |||||
5 | piperiacetidenafil (苯噻啶红地那非) | C24H31N5O3 | 438.24939 | 297.12422, 341.16089 | 5.93 | [M+H]+ | |||||
6 | benzocaine (苯佐卡因) | C9H11NO2 | 166.08601 | 138.05492, 120.04429 | 6.31 | [M+H]+ | |||||
7 | bendroflumethiazide (苄氟噻嗪) | C15H14F3N3O4S2 | 420.03149 | 289.04599, 327.96851 | 7.13 | [M-H]- | |||||
8 | yohimbine (育亨宾) | C21H26N2O3 | 355.20090 | 212.12802, 144.08075 | 5.43 | [M+H]+ | |||||
9 | hydroxyacetildenafil (羟基红地那非) | C25H34N6O4 | 483.27103 | 297.13419, 127.08654 | 5.73 | [M+H]+ | |||||
10 | hydroxythiohomo sildenafil (羟基硫代豪莫西地那非) | C23H32N6O4S2 | 521.19958 | 299.09589, 327.12759 | 6.74 | [M+H]+ | |||||
11 | hydroxyvardenafil (羟基伐地那非) | C23H32N6O5S | 505.22235 | 344.14746, 169.09691 | 5.73 | [M+H]+ | |||||
12 | thiohomo sildenafil (硫代豪莫西地那非) | C23H32N6O3S2 | 505.20401 | 299.09607, 113.10741 | 6.92 | [M+H]+ | |||||
13 | thiosildenafil (硫代西地那非) | C22H30N6O3S2 | 491.18918 | 341.14389, 407.12027 | 6.82 | [M+H]+ | |||||
14 | N-desmethylsibutramine hydrochloride | C16H24ClN·HCl | 266.16666 | 125.01524, 139.03091 | 6.72 | [M+H]+ | |||||
(盐酸N-单去甲基西布曲明) | |||||||||||
15 | N,N-didesmethylsibutramine hydrochloride | C15H22ClN·HCl | 252.15092 | 125.01521, 139.03085 | 6.69 | [M+H]+ | |||||
(盐酸N,N-双去甲基西布曲明) | |||||||||||
16 | chlorthalidone (氯噻酮) | C14H11CLN2O4S | 337.00583 | 146.02345, 189.97272 | 5.70 | [M-H]- | |||||
17 | lorcaserin (氯卡色林) | C11H14ClN | 196.08885 | 179.06218, 167.06212 | 5.52 | [M+H]+ | |||||
18 | hydrochlorothiazide (氢氯噻嗪) | C7H8ClN3O4S2 | 295.95804 | 268.94708, 204.98419 | 3.06 | [M-H]- | |||||
19 | torasemide (托拉塞米) | C16H20N4O3S | 347.11835 | 262.06564, 195.07954 | 6.04 | [M-H]- | |||||
20 | gendenafil (庆地那非) | C19H22N4O3 | 355.17612 | 327.14514, 285.13467 | 7.44 | [M+H]+ | |||||
21 | emodin (大黄素) | C15H10O5 | 269.04623 | 225.05583, 241.05090 | 8.11 | [M-H]- | |||||
22 | indapamide (吲达帕胺) | C16H16O3N3ClS | 366.06686 | 132.08073, 117.05728 | 6.75 | [M+H]+ | |||||
23 | desmethyl sildenafil (去甲基西地那非) | C21H28N6O4S | 461.19626 | 283.11868, 255.12376 | 5.97 | [M+H]+ | |||||
24 | desmethyl thiosildenafil (去甲基硫代西地那非) | C21H28N6O3S2 | 477.17288 | 299.09586, 315.09033 | 6.79 | [M+H]+ | |||||
25 | nortadalafil (去甲他达拉非) | C21H17N3O4 | 376.12857 | 262.08588, 254.09195 | 6.69 | [M+H]+ | |||||
No. | Compound | Formula | Measured mass (m/z) | Fragments (m/z) | tR/min | Adduct | |||||
26 | N-desethyl acetildenafil (去乙基红地那非) | C23H30N6O3 | 439.24466 | 297.13419, 313.12927 | 5.78 | [M+H]+ | |||||
27 | N-desethyl vardenafil (去乙基伐地那非) | C21H28N6O4S | 461.19577 | 344.14749, 299.11346 | 5.97 | [M+H]+ | |||||
28 | rimonabant (利莫那班) | C22H21Cl3N4O | 463.08517 | 380.99548, 299.01343 | 9.08 | [M+H]+ | |||||
29 | lidocaine (利多卡因) | C14H22N2O | 235.18016 | 86.09662, 58.06575 | 4.33 | [M+H]+ | |||||
30 | chlorpretadalafil (他达拉非甲基氯化物) | C22H19ClN2O5 | 337.00583 | 146.02345, 189.97272 | 7.91 | [M+H]+ | |||||
31 | dimethylsildenafil (二甲基西地那非) | C23H32N6O4S | 489.22803 | 283.11920, 344.14856 | 6.14 | [M+H]+ | |||||
32 | udenafil (乌地那非) | C25H36N6O4S | 517.25854 | 283.11874, 299.11380 | 6.22 | [M+H]+ |
Fig. 1 Extracted ion chromatograms of the 32 compounds (spiked at 1.0 mg/kg) For peak numbers 1-32, see Table 1. No. 7, 16, 18, 19, 21 were collected in ESI- mode, the others were collected in ESI+ mode.
No. | Compound | Solid sample | Liquid sample | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Linear equation | Linear range* | r2 | LOD/ (mg/kg) | Linear equation | Linear range* | r2 | LOD/ (mg/kg) | ||||
1 | avanafil | y=2.41×106x+4.55×107 | 5-500 | 0.9924 | 0.02 | y=2.13×106x+3.66×107 | 5-500 | 0.9941 | 0.02 | ||
2 | acetilacid | y=2.20×106x+4.16×106 | 5-200 | 0.9985 | 0.02 | y=2.03×106x+2.14×107 | 5-500 | 0.9970 | 0.02 | ||
3 | dapoxetine | y=5.47×106x+4.90×107 | 5-500 | 0.9972 | 0.02 | y=5.00×106x+7.34×107 | 5-500 | 0.9960 | 0.02 | ||
4 | xanthoanthrafil | y=5.76×105x+7.49×106 | 5-500 | 0.9917 | 0.02 | y=5.22×105x+4.97×106 | 5-500 | 0.9977 | 0.02 | ||
5 | piperiacetidenafil | y=3.00×106x+8.73×106 | 5-200 | 0.9988 | 0.02 | y=2.81×106x+6.18×107 | 5-500 | 0.9922 | 0.02 | ||
6 | benzocaine | y=4.12×106x-9.63×106 | 5-200 | 0.9914 | 0.02 | y=3.74×106x+3.60×107 | 5-500 | 0.9970 | 0.02 | ||
7 | bendroflumethiazide | y=1.15×106x+1.90×106 | 5-500 | 0.9943 | 0.02 | y=1.01×106x+1.52×107 | 5-500 | 0.9951 | 0.02 | ||
8 | yohimbine | y=2.81×106x+1.01×106 | 5-200 | 0.9952 | 0.02 | y=6.53×106x+3.99×106 | 5-200 | 0.9982 | 0.02 | ||
9 | hydroxyacetildenafil | y=1.29×106x+1.55×105 | 5-200 | 0.9983 | 0.02 | y=9.64×105x+7.38×105 | 5-200 | 0.9952 | 0.02 | ||
10 | hydroxythiohomo sildenafil | y=1.38×106x+2.81×106 | 5-200 | 0.9962 | 0.02 | y=7.16×105x+5.72×106 | 5-500 | 0.9978 | 0.02 | ||
11 | hydroxyvardenafil | y=3.93×105x+4.73×105 | 5-200 | 0.9976 | 0.02 | y=9.49×105x+3.17×105 | 5-200 | 0.9932 | 0.02 | ||
12 | thiohomo sildenafil | y=2.27×106x+4.87×106 | 5-200 | 0.9938 | 0.02 | y=1.35×106x+1.45×107 | 5-500 | 0.9942 | 0.02 | ||
13 | thiosildenafil | y=2.25×106x-3.53×106 | 5-200 | 0.9995 | 0.02 | y=1.03×106x+1.31×107 | 5-500 | 0.9943 | 0.02 | ||
14 | N-desmethylsibutramine | y=2.82×106x+1.10×106 | 5-200 | 0.9975 | 0.02 | y=3.38×106x+1.48×107 | 5-200 | 0.9945 | 0.02 | ||
hydrochloride | |||||||||||
15 | N,N-didesmethylsibutramine | y=1.27×106x+1.05×106 | 5-200 | 0.9982 | 0.02 | y=1.43×106x+5.65×106 | 5-200 | 0.9904 | 0.02 | ||
hydrochloride | |||||||||||
16 | chlorthalidone | y=2.24×105x+2.05×105 | 5-200 | 0.9966 | 0.04 | y=3.20×105x+2.39×106 | 5-500 | 0.9983 | 0.02 | ||
17 | lorcaserin | y=2.98×106x+3.97×106 | 5-200 | 0.9945 | 0.02 | y=3.03×106x+1.11×107 | 5-200 | 0.9946 | 0.02 | ||
18 | hydrochlorothiazide | y=3.00×105x-1.73×105 | 5-200 | 0.9997 | 0.02 | y=2.98×105x+1.04×106 | 5-200 | 0.9943 | 0.02 | ||
19 | torasemide | y=9.78×105x+2.87×106 | 5-500 | 0.9983 | 0.02 | y=8.06×105x+1.05×106 | 5-500 | 0.9964 | 0.02 | ||
20 | gendenafil | y=3.63×106x+2.27×107 | 5-500 | 0.9985 | 0.02 | y=3.29×106x+4.60×107 | 5-500 | 0.9949 | 0.02 | ||
21 | emodin | y=2.60×106x+2.51×106 | 5-200 | 0.9916 | 0.02 | y=2.96×106x+1.20×106 | 5-200 | 0.9926 | 0.02 | ||
22 | indapamide | y=5.13×105x+6.57×106 | 5-500 | 0.9921 | 0.02 | y=4.69×105x+3.35×106 | 5-500 | 0.9986 | 0.02 | ||
23 | desmethyl sildenafil | y=1.12×106x+1.76×106 | 5-200 | 0.9940 | 0.02 | y=8.79×105x+5.67×106 | 5-200 | 0.9904 | 0.02 | ||
24 | desmethyl thiosildenafil | y=1.02×106x+2.03×106 | 5-500 | 0.9985 | 0.04 | y=7.90×105x+7.91×106 | 5-500 | 0.9979 | 0.02 | ||
25 | nortadalafil | y=4.84×106x-1.01×106 | 5-500 | 1 | 0.02 | y=4.35×105x+3.97×106 | 5-500 | 0.9974 | 0.02 | ||
26 | N-desethyl acetildenafil | y=7.81×105x-4.59×105 | 5-200 | 0.9983 | 0.02 | y=7.06×105x+7.71×105 | 5-200 | 0.9962 | 0.02 | ||
27 | N-desethyl vardenafil | y=6.65×106x+1.03×106 | 5-200 | 0.9967 | 0.02 | y=8.87×105x+5.66×106 | 5-200 | 0.9904 | 0.02 | ||
28 | rimonabant | y=2.46×106x+2.68×106 | 5-200 | 0.9953 | 0.02 | y=2.74×106x+2.04×106 | 5-200 | 0.9981 | 0.02 | ||
29 | lidocaine | y=5.97×106x+1.78×107 | 5-200 | 0.9954 | 0.02 | y=5.42×106x+2.67×107 | 5-200 | 0.9929 | 0.02 | ||
30 | chlorpretadalafil | y=1.81×105x+5.23×104 | 5-500 | 0.9998 | 0.02 | y=1.67×105x+8.56×105 | 5-500 | 0.9990 | 0.02 | ||
31 | dimethylsildenafil | y=1.84×106x+8.15×106 | 5-200 | 0.9946 | 0.02 | y=1.16×106x+2.08×107 | 5-500 | 0.9917 | 0.02 | ||
32 | udenafil | y=4.67×106x+1.09×106 | 5-200 | 0.9982 | 0.04 | y=1.51×106x+4.89×107 | 5-200 | 0.9940 | 0.02 |
Table 2 Linear equations, linear ranges, correlation coefficients (r2), and LODs of the 32 compounds
No. | Compound | Solid sample | Liquid sample | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Linear equation | Linear range* | r2 | LOD/ (mg/kg) | Linear equation | Linear range* | r2 | LOD/ (mg/kg) | ||||
1 | avanafil | y=2.41×106x+4.55×107 | 5-500 | 0.9924 | 0.02 | y=2.13×106x+3.66×107 | 5-500 | 0.9941 | 0.02 | ||
2 | acetilacid | y=2.20×106x+4.16×106 | 5-200 | 0.9985 | 0.02 | y=2.03×106x+2.14×107 | 5-500 | 0.9970 | 0.02 | ||
3 | dapoxetine | y=5.47×106x+4.90×107 | 5-500 | 0.9972 | 0.02 | y=5.00×106x+7.34×107 | 5-500 | 0.9960 | 0.02 | ||
4 | xanthoanthrafil | y=5.76×105x+7.49×106 | 5-500 | 0.9917 | 0.02 | y=5.22×105x+4.97×106 | 5-500 | 0.9977 | 0.02 | ||
5 | piperiacetidenafil | y=3.00×106x+8.73×106 | 5-200 | 0.9988 | 0.02 | y=2.81×106x+6.18×107 | 5-500 | 0.9922 | 0.02 | ||
6 | benzocaine | y=4.12×106x-9.63×106 | 5-200 | 0.9914 | 0.02 | y=3.74×106x+3.60×107 | 5-500 | 0.9970 | 0.02 | ||
7 | bendroflumethiazide | y=1.15×106x+1.90×106 | 5-500 | 0.9943 | 0.02 | y=1.01×106x+1.52×107 | 5-500 | 0.9951 | 0.02 | ||
8 | yohimbine | y=2.81×106x+1.01×106 | 5-200 | 0.9952 | 0.02 | y=6.53×106x+3.99×106 | 5-200 | 0.9982 | 0.02 | ||
9 | hydroxyacetildenafil | y=1.29×106x+1.55×105 | 5-200 | 0.9983 | 0.02 | y=9.64×105x+7.38×105 | 5-200 | 0.9952 | 0.02 | ||
10 | hydroxythiohomo sildenafil | y=1.38×106x+2.81×106 | 5-200 | 0.9962 | 0.02 | y=7.16×105x+5.72×106 | 5-500 | 0.9978 | 0.02 | ||
11 | hydroxyvardenafil | y=3.93×105x+4.73×105 | 5-200 | 0.9976 | 0.02 | y=9.49×105x+3.17×105 | 5-200 | 0.9932 | 0.02 | ||
12 | thiohomo sildenafil | y=2.27×106x+4.87×106 | 5-200 | 0.9938 | 0.02 | y=1.35×106x+1.45×107 | 5-500 | 0.9942 | 0.02 | ||
13 | thiosildenafil | y=2.25×106x-3.53×106 | 5-200 | 0.9995 | 0.02 | y=1.03×106x+1.31×107 | 5-500 | 0.9943 | 0.02 | ||
14 | N-desmethylsibutramine | y=2.82×106x+1.10×106 | 5-200 | 0.9975 | 0.02 | y=3.38×106x+1.48×107 | 5-200 | 0.9945 | 0.02 | ||
hydrochloride | |||||||||||
15 | N,N-didesmethylsibutramine | y=1.27×106x+1.05×106 | 5-200 | 0.9982 | 0.02 | y=1.43×106x+5.65×106 | 5-200 | 0.9904 | 0.02 | ||
hydrochloride | |||||||||||
16 | chlorthalidone | y=2.24×105x+2.05×105 | 5-200 | 0.9966 | 0.04 | y=3.20×105x+2.39×106 | 5-500 | 0.9983 | 0.02 | ||
17 | lorcaserin | y=2.98×106x+3.97×106 | 5-200 | 0.9945 | 0.02 | y=3.03×106x+1.11×107 | 5-200 | 0.9946 | 0.02 | ||
18 | hydrochlorothiazide | y=3.00×105x-1.73×105 | 5-200 | 0.9997 | 0.02 | y=2.98×105x+1.04×106 | 5-200 | 0.9943 | 0.02 | ||
19 | torasemide | y=9.78×105x+2.87×106 | 5-500 | 0.9983 | 0.02 | y=8.06×105x+1.05×106 | 5-500 | 0.9964 | 0.02 | ||
20 | gendenafil | y=3.63×106x+2.27×107 | 5-500 | 0.9985 | 0.02 | y=3.29×106x+4.60×107 | 5-500 | 0.9949 | 0.02 | ||
21 | emodin | y=2.60×106x+2.51×106 | 5-200 | 0.9916 | 0.02 | y=2.96×106x+1.20×106 | 5-200 | 0.9926 | 0.02 | ||
22 | indapamide | y=5.13×105x+6.57×106 | 5-500 | 0.9921 | 0.02 | y=4.69×105x+3.35×106 | 5-500 | 0.9986 | 0.02 | ||
23 | desmethyl sildenafil | y=1.12×106x+1.76×106 | 5-200 | 0.9940 | 0.02 | y=8.79×105x+5.67×106 | 5-200 | 0.9904 | 0.02 | ||
24 | desmethyl thiosildenafil | y=1.02×106x+2.03×106 | 5-500 | 0.9985 | 0.04 | y=7.90×105x+7.91×106 | 5-500 | 0.9979 | 0.02 | ||
25 | nortadalafil | y=4.84×106x-1.01×106 | 5-500 | 1 | 0.02 | y=4.35×105x+3.97×106 | 5-500 | 0.9974 | 0.02 | ||
26 | N-desethyl acetildenafil | y=7.81×105x-4.59×105 | 5-200 | 0.9983 | 0.02 | y=7.06×105x+7.71×105 | 5-200 | 0.9962 | 0.02 | ||
27 | N-desethyl vardenafil | y=6.65×106x+1.03×106 | 5-200 | 0.9967 | 0.02 | y=8.87×105x+5.66×106 | 5-200 | 0.9904 | 0.02 | ||
28 | rimonabant | y=2.46×106x+2.68×106 | 5-200 | 0.9953 | 0.02 | y=2.74×106x+2.04×106 | 5-200 | 0.9981 | 0.02 | ||
29 | lidocaine | y=5.97×106x+1.78×107 | 5-200 | 0.9954 | 0.02 | y=5.42×106x+2.67×107 | 5-200 | 0.9929 | 0.02 | ||
30 | chlorpretadalafil | y=1.81×105x+5.23×104 | 5-500 | 0.9998 | 0.02 | y=1.67×105x+8.56×105 | 5-500 | 0.9990 | 0.02 | ||
31 | dimethylsildenafil | y=1.84×106x+8.15×106 | 5-200 | 0.9946 | 0.02 | y=1.16×106x+2.08×107 | 5-500 | 0.9917 | 0.02 | ||
32 | udenafil | y=4.67×106x+1.09×106 | 5-200 | 0.9982 | 0.04 | y=1.51×106x+4.89×107 | 5-200 | 0.9940 | 0.02 |
No. | Compound | Recoveries (RSDs) in solid sample/% | Recoveries (RSDs) in liquid sample/% | ||||||
---|---|---|---|---|---|---|---|---|---|
0.2 mg/kg | 0.6 mg/kg | 1.0 mg/kg | 0.2 mg/kg | 0.6 mg/kg | 1.0 mg/kg | ||||
1 | avanafil | 74.2(2.2) | 53.9(5.2) | 74.7(10) | 72.5(2.5) | 85.7(3.4) | 86.5(5.2) | ||
2 | acetilacid | 78.6(1.8) | 82.7(2.8) | 78.3(5.1) | 70.2(3.8) | 88.3(2.0) | 92.4(2.1) | ||
3 | dapoxetine | 50.5(1.5) | 36.9(3.1) | 49.9(4.1) | 71.8(2.1) | 96.1(2.0) | 96.9(3.1) | ||
4 | xanthoanthrafil | 69.9(4.8) | 54.5(3.7) | 75.3(4.2) | 77.6(3.4) | 98.7(2.0) | 94.4(1.2) | ||
5 | piperiacetidenafil | 72.7(2.0) | 76.9(2.6) | 74.6(7.8) | 88.2(4.3) | 92.1(5.0) | 94.9(6.0) | ||
6 | benzocaine | 84.3(12) | 73.4(5.1) | 70.0(3.0) | 78.5(6.4) | 91.2(8.2) | 109.3(5.2) | ||
7 | bendroflumethiazide | 77.5(4.0) | 81.2(3.2) | 73.1(3.7) | 75.0(5.3) | 84.3(2.5) | 86.3(3.6) | ||
8 | yohimbine | 74.3(2.4) | 77.0(3.8) | 78.7(6.0) | 66.6(2.5) | 86.7(2.7) | 94.1(2.1) | ||
9 | hydroxyacetildenafil | 71.6(2.9) | 76.4(3.4) | 70.4(7.4) | 62.1(3.4) | 77.1(1.5) | 83.4(2.8) | ||
10 | hydroxythiohomo sildenafil | 69.7(3.2) | 41.0(3.7) | 59.2(9.3) | 77.2(4.3) | 91.3(2.1) | 85.9(1.6) | ||
11 | hydroxyvardenafil | 67.6(3.4) | 70.9(3.4) | 67.8(8.5) | 71.2(2.9) | 82.2(1.5) | 87.7(2.9) | ||
12 | thiohomo sildenafil | 49.8(3.2) | 23.4(3.1) | 36.7(9.2) | 64.9(5.1) | 86.7(2.6) | 88.5(2.2) | ||
13 | thiosildenafil | 64.3(5.0) | 36.5(2.6) | 53.2(10) | 74.3(4.4) | 93.4(1.6) | 94.0(1.7) | ||
14 | N-desmethylsibutramine hydrochloride | 69.6(2.2) | 74.2(2.7) | 70.7(3.0) | 67.7(2.8) | 88.1(2.4) | 98.1(1.2) | ||
15 | N,N-didesmethylsibutramine hydrochloride | 66.2(3.3) | 81.2(2.8) | 70.1(5.0) | 60.4(1.1) | 83.1(2.5) | 90.5(1.0) | ||
16 | chlorthalidone | 84.1(5.8) | 59.6(5.9) | 65.7(5.1) | 80.5(3.2) | 102.0(3.0) | 99.3(2.5) | ||
17 | lorcaserin | 72.6(2.1) | 75.8(3.6) | 74.5(5.4) | 76.0(1.6) | 88.5(1.6) | 94.4(2.1) | ||
18 | hydrochlorothiazide | 74.1(7.4) | 83.7(2.0) | 73.3(4.3) | 78.6(2.0) | 88.2(1.3) | 89.6(0.99) | ||
19 | torasemide | 78.6(5.5) | 84.5(3.8) | 77.1(5.0) | 73.3(4.5) | 93.3(3.8) | 92.1(2.3) | ||
20 | gendenafil | 80.3(1.2) | 54.3(3.9) | 73.5(5.5) | 85.3(3.7) | 107.3(1.2) | 100.0(2.3) | ||
21 | emodin | 64.5(2.4) | 73.0(3.1) | 66.7(2.4) | 81.6(4.5) | 86.8(3.0) | 90.2(2.5) | ||
22 | indapamide | 78.7(5.1) | 80.4(1.4) | 77.5(8.1) | 78.8(3.0) | 91.3(1.9) | 91.9(2.1) | ||
23 | desmethyl sildenafil | 68.5(4.5) | 74.6(3.4) | 70.5(8.4) | 74.6(2.5) | 87.2(0.77) | 90.3(2.8) | ||
24 | desmethyl thiosildenafil | 45.8(6.2) | 24.9(3.2) | 38.3(11) | 71.4(3.2) | 95.9(2.9) | 93.2(2.3) | ||
25 | nortadalafil | 69.2(13) | 71.9(5.5) | 71.9(8.6) | 68.4(7.9) | 95.0(4.7) | 91.4(3.0) | ||
26 | N-desethyl acetildenafil | 76.4(2.6) | 78.8(1.7) | 74.2(8.2) | 76.3(3.1) | 88.0(1.2) | 91.2(1.4) | ||
27 | N-desethyl vardenafil | 68.5(4.5) | 74.6(3.4) | 70.5(10) | 74.6(2.5) | 87.2(0.78) | 90.2(2.8) | ||
28 | rimonabant | 71.7(3.6) | 72.3(1.8) | 69.3(7.1) | 91.7(1.6) | 96.1(2.1) | 99.9(3.7) | ||
29 | lidocaine | 75.4(1.6) | 74.7(2.9) | 75.7(7.9) | 80.0(1.4) | 89.4(2.9) | 95.5(2.4) | ||
30 | chlorpretadalafil | 53.7(6.3) | 72.9(5.2) | 73.5(10) | 69.5(7.5) | 79.5(2.3) | 89.8(5.7) | ||
31 | dimethylsildenafil | 72.2(3.7) | 54.6(2.6) | 72.2(6.2) | 79.8(5.2) | 104.1(3.4) | 97.5(2.1) | ||
32 | udenafil | 70.7(3.6) | 51.3(3.4) | 70.6(8.5) | 67.2(2.8) | 85.7(1.8) | 88.7(2.5) |
Table 3 Recoveries and RSDs of the 32 compounds spiked in different blank samples at three levels (n=6)
No. | Compound | Recoveries (RSDs) in solid sample/% | Recoveries (RSDs) in liquid sample/% | ||||||
---|---|---|---|---|---|---|---|---|---|
0.2 mg/kg | 0.6 mg/kg | 1.0 mg/kg | 0.2 mg/kg | 0.6 mg/kg | 1.0 mg/kg | ||||
1 | avanafil | 74.2(2.2) | 53.9(5.2) | 74.7(10) | 72.5(2.5) | 85.7(3.4) | 86.5(5.2) | ||
2 | acetilacid | 78.6(1.8) | 82.7(2.8) | 78.3(5.1) | 70.2(3.8) | 88.3(2.0) | 92.4(2.1) | ||
3 | dapoxetine | 50.5(1.5) | 36.9(3.1) | 49.9(4.1) | 71.8(2.1) | 96.1(2.0) | 96.9(3.1) | ||
4 | xanthoanthrafil | 69.9(4.8) | 54.5(3.7) | 75.3(4.2) | 77.6(3.4) | 98.7(2.0) | 94.4(1.2) | ||
5 | piperiacetidenafil | 72.7(2.0) | 76.9(2.6) | 74.6(7.8) | 88.2(4.3) | 92.1(5.0) | 94.9(6.0) | ||
6 | benzocaine | 84.3(12) | 73.4(5.1) | 70.0(3.0) | 78.5(6.4) | 91.2(8.2) | 109.3(5.2) | ||
7 | bendroflumethiazide | 77.5(4.0) | 81.2(3.2) | 73.1(3.7) | 75.0(5.3) | 84.3(2.5) | 86.3(3.6) | ||
8 | yohimbine | 74.3(2.4) | 77.0(3.8) | 78.7(6.0) | 66.6(2.5) | 86.7(2.7) | 94.1(2.1) | ||
9 | hydroxyacetildenafil | 71.6(2.9) | 76.4(3.4) | 70.4(7.4) | 62.1(3.4) | 77.1(1.5) | 83.4(2.8) | ||
10 | hydroxythiohomo sildenafil | 69.7(3.2) | 41.0(3.7) | 59.2(9.3) | 77.2(4.3) | 91.3(2.1) | 85.9(1.6) | ||
11 | hydroxyvardenafil | 67.6(3.4) | 70.9(3.4) | 67.8(8.5) | 71.2(2.9) | 82.2(1.5) | 87.7(2.9) | ||
12 | thiohomo sildenafil | 49.8(3.2) | 23.4(3.1) | 36.7(9.2) | 64.9(5.1) | 86.7(2.6) | 88.5(2.2) | ||
13 | thiosildenafil | 64.3(5.0) | 36.5(2.6) | 53.2(10) | 74.3(4.4) | 93.4(1.6) | 94.0(1.7) | ||
14 | N-desmethylsibutramine hydrochloride | 69.6(2.2) | 74.2(2.7) | 70.7(3.0) | 67.7(2.8) | 88.1(2.4) | 98.1(1.2) | ||
15 | N,N-didesmethylsibutramine hydrochloride | 66.2(3.3) | 81.2(2.8) | 70.1(5.0) | 60.4(1.1) | 83.1(2.5) | 90.5(1.0) | ||
16 | chlorthalidone | 84.1(5.8) | 59.6(5.9) | 65.7(5.1) | 80.5(3.2) | 102.0(3.0) | 99.3(2.5) | ||
17 | lorcaserin | 72.6(2.1) | 75.8(3.6) | 74.5(5.4) | 76.0(1.6) | 88.5(1.6) | 94.4(2.1) | ||
18 | hydrochlorothiazide | 74.1(7.4) | 83.7(2.0) | 73.3(4.3) | 78.6(2.0) | 88.2(1.3) | 89.6(0.99) | ||
19 | torasemide | 78.6(5.5) | 84.5(3.8) | 77.1(5.0) | 73.3(4.5) | 93.3(3.8) | 92.1(2.3) | ||
20 | gendenafil | 80.3(1.2) | 54.3(3.9) | 73.5(5.5) | 85.3(3.7) | 107.3(1.2) | 100.0(2.3) | ||
21 | emodin | 64.5(2.4) | 73.0(3.1) | 66.7(2.4) | 81.6(4.5) | 86.8(3.0) | 90.2(2.5) | ||
22 | indapamide | 78.7(5.1) | 80.4(1.4) | 77.5(8.1) | 78.8(3.0) | 91.3(1.9) | 91.9(2.1) | ||
23 | desmethyl sildenafil | 68.5(4.5) | 74.6(3.4) | 70.5(8.4) | 74.6(2.5) | 87.2(0.77) | 90.3(2.8) | ||
24 | desmethyl thiosildenafil | 45.8(6.2) | 24.9(3.2) | 38.3(11) | 71.4(3.2) | 95.9(2.9) | 93.2(2.3) | ||
25 | nortadalafil | 69.2(13) | 71.9(5.5) | 71.9(8.6) | 68.4(7.9) | 95.0(4.7) | 91.4(3.0) | ||
26 | N-desethyl acetildenafil | 76.4(2.6) | 78.8(1.7) | 74.2(8.2) | 76.3(3.1) | 88.0(1.2) | 91.2(1.4) | ||
27 | N-desethyl vardenafil | 68.5(4.5) | 74.6(3.4) | 70.5(10) | 74.6(2.5) | 87.2(0.78) | 90.2(2.8) | ||
28 | rimonabant | 71.7(3.6) | 72.3(1.8) | 69.3(7.1) | 91.7(1.6) | 96.1(2.1) | 99.9(3.7) | ||
29 | lidocaine | 75.4(1.6) | 74.7(2.9) | 75.7(7.9) | 80.0(1.4) | 89.4(2.9) | 95.5(2.4) | ||
30 | chlorpretadalafil | 53.7(6.3) | 72.9(5.2) | 73.5(10) | 69.5(7.5) | 79.5(2.3) | 89.8(5.7) | ||
31 | dimethylsildenafil | 72.2(3.7) | 54.6(2.6) | 72.2(6.2) | 79.8(5.2) | 104.1(3.4) | 97.5(2.1) | ||
32 | udenafil | 70.7(3.6) | 51.3(3.4) | 70.6(8.5) | 67.2(2.8) | 85.7(1.8) | 88.7(2.5) |
|
[1] | CAO Qinling, ZHAO Xiaodan, SHEN Guobin, WANG Zhuqin, ZHANG Hongyang, ZHANG Min, HU Ping. Fingerprint of sophorolipids based on ultra-high performance liquid chromatography-charged aerosol detection [J]. Chinese Journal of Chromatography, 2023, 41(8): 722-729. |
[2] | CHEN Jia, LIU Yulong, XU Bin, LIU Qin, XIE Jianwei. Rapid screening of Chemical Weapons Convention-related chemicals in oil matrix by headspace solid-phase microextraction and gas chromatography-mass spectrometry [J]. Chinese Journal of Chromatography, 2023, 41(4): 348-358. |
[3] | LIU Yapeng, ZHANG Wang, LIU Xinjie, WU Huan, ZHOU An. Determination of complexation ability of rhubarb with copper ions by ultra-high performance liquid chromatography [J]. Chinese Journal of Chromatography, 2023, 41(4): 323-329. |
[4] | NING Xiao, JIN Shaoming, LI Zhiyuan, YANG Chongjun, MAO Da, CAO Jin. Liquid chromatography-high resolution mass spectrometry analysis of 300 illegally added drugs and their analogues in functional milk powder for the elderly [J]. Chinese Journal of Chromatography, 2023, 41(11): 960-975. |
[5] | LI Tonghui, FENG Feng, SHEN Yiming, ZHANG Feng. Rapid determination of 13 β-blockers in health foods by ultra performance liquid chromatography-quadrupole/electrostatic field orbitrap mass spectrometry [J]. Chinese Journal of Chromatography, 2023, 41(11): 1030-1037. |
[6] | XIONG Chensihui, DING Tianming, LIU Jie, YI Ou, DING Xiaoping, XIE Yun. Rapid determination of 22 functional components in cosmetics using ultra-high performance liquid chromatography-linear ion trap/orbitrap high resolution mass spectrometry [J]. Chinese Journal of Chromatography, 2022, 40(9): 817-824. |
[7] | ZHANG Quan, BI Shan, WU Yutian, LI Lei, ZHOU Yibing, LIU Liya, LIU Wenzheng, CHEN Qingyuan, ZHOU Xue, GUO Hua. Rapid screening of 84 pesticide residues in dendrobium by Sin-QuEChERS Nano purification column with gas chromatography-tandem mass spectrometry [J]. Chinese Journal of Chromatography, 2022, 40(6): 565-575. |
[8] | KE Qingqing, LI Shiyan, WANG Dingnan, ZHOU Qin, ZHOU Fan, BEI Yijiang, CHEN Xiaoming, WANG Yang. Rapid screening and confirmation of 86 illegally added chemicals in fishery drugs by ultra performance liquid chromatography-quadrupole-time-of-flight mass spectrometry [J]. Chinese Journal of Chromatography, 2022, 40(6): 520-530. |
[9] | LI Jiachen, CAO Ling, FANG Fang, SHI Haiwei, HUANG Qing, TAN Li, DUAN Qiaolian, FENG Youlong. Rapid determination of 10 fat-soluble vitamins in health foods by ultra performance convergence chromatography [J]. Chinese Journal of Chromatography, 2022, 40(12): 1136-1142. |
[10] | XUE Gaoxu, WANG Qinyi, CAO Ling, SUN Jing, YANG Gongjun, FENG Youlong, FANG Fang. Rapid screening of 14 antibacterial drugs in anti-acne cosmetics using ion mobility spectrometry coupled with solid-phase extraction [J]. Chinese Journal of Chromatography, 2022, 40(12): 1119-1127. |
[11] | SHEN Shuchang, LI Shaohua, GUO Li, LÜ Weichao, LI Qiushi. Design and application of special solid phase extraction column for three cannabinol compounds in hemp [J]. Chinese Journal of Chromatography, 2021, 39(5): 534-540. |
[12] | CHEN Shudong, FENG Rui, LIN Xiaojia, LIANG Tujin, HE Qiuting. Determination of nine ginsenosides in health foods by solid extraction phase-ultra performance liquid chromatography-tandem mass spectrometry [J]. Chinese Journal of Chromatography, 2021, 39(5): 526-533. |
[13] | ZHANG Keming, DENG Ming, SU Yuanyuan, XIE Dong, XU Youcheng, LIU Xianghong. Simultaneous determination of 22 sunscreen agents in cosmetics by ultra-high-performance liquid chromatography using diode array detector [J]. Chinese Journal of Chromatography, 2021, 39(4): 415-423. |
[14] | XU Dunming, LAI Guoyin, CHEN Yan, LUO Chao, YI Xionghai, DENG Xiaojun, FENG Feng, ZHANG Feng. Simultaneous determination of 21 illegally added compounds in health foods by ultra high performance liquid chromatography-tandem mass spectrometry with solid phase extraction [J]. Chinese Journal of Chromatography, 2019, 37(7): 778-785. |
[15] | HU Qiaoru, CAO Peng, CONG Zhongxiao, LIANG Junni, SHA Meilan, LI Xiaoyu, YIN Dalu, LU Min. Rapid screening and confirmation of 20 mycotoxins in grain products by ultrahigh performance liquid chromatography- quadrupole/electrostatic field orbitrap high- resolution mass spectrometry [J]. Chinese Journal of Chromatography, 2019, 37(11): 1241-1248. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||